U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

NewsGuard 100/100 Score

U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, announced that it has successfully launched a workers compensation and disability initiative called Fit2WRK. Fit2WRK provides an integrated solution for the management and prevention of injuries in the workplace. Through Fit2WRK, U.S. Physical Therapy has secured a number of network and employer direct agreements. From auto manufacturing to fabrication, chemical processing plants, logistics companies, housing supplies and grocery chains, Fit2WRK is proving to reduce loss time and employer cost from injury as well as to expedite employee return to work. Programs are designed around the higher risk jobs in the workplace involving potential musculoskeletal disorders.

The successful launch of Fit2WRK was accomplished through education and training programs combined with the addition of regional industrial specialists enabling the Company to increase exposure and secure business for the Fit2WRK program. In 2011, U.S. Physical Therapy through Fit2WRK intends to continue to establish national contracts with networks, employers, third party administrators and case managers.

Through its extensive service offering and proprietary solutions for employers, Fit2WRK is proving to be a significant value. Ray Gagne, Vice President-Workers Compensation and Disability, said, "We are pleased with the positive impact we have made this past year with Fit2WRK. From conception to roll out we have taken the time to understand the needs of the user community and are excited about the opportunities."

Gagne continued, "U.S. Physical Therapy and our affiliates are well situated from both a geographical footprint and clinical experience standpoint to increase our base in the workers compensation and disability market."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients